Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2012
12/11/2012US8329654 Use of IL-6/IL-6 chimera in Huntington's disease
12/11/2012US8329463 RNA interference mediating small RNA molecules
12/11/2012US8329462 Methods and compositions relating to improved lentiviral vectors and their applications
12/11/2012US8329163 Attenuated gram negative bacteria
12/11/2012CA2650202C Esters of l-carnitine or alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
12/11/2012CA2481479C Novel flavivirus antigens
12/11/2012CA2202519C Cloning, expression and characterization of a new form of phosphatidylinositol-3-kinase
12/06/2012WO2012167214A1 Compositions and methods for transport across the blood brain barrier
12/06/2012WO2012167109A2 Rpgrip1 gene therapy for leber congenital amaurosis
12/06/2012WO2012166875A2 Modulating innate immune cell activity by lunasin and selected cytokines
12/06/2012WO2012166859A2 Modulation of sphingosine 1-phosphate metabolizing enzymes for the treatment of negative-strand rna virus infections
12/06/2012WO2012166646A1 TARGETING p63 TO RE-ACTIVATE DORMANT RESERVE STEM CELLS IN OLFACTORY EPITHELIUM
12/06/2012WO2012166588A2 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
12/06/2012WO2012165854A2 Long interfering dsrna simultaneously inducing an immune reaction and the inhibition of the expression of target genes
12/06/2012WO2012165653A1 Improved oligonucleotide and pharmaceutical composition containing said oligonucleotide
12/06/2012WO2012165616A1 OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE DERIVATIVE-CONTAINING PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PHARMACEUTICAL COMPOSITION FOR DIAGNOSIS, AND OLIGONUCLEOTIDE DERIVATIVE FOR REGULATION OF miRNA FUNCTION
12/06/2012WO2012164936A1 Suv39h2 as a target gene for cancer therapy and diagnosis
12/06/2012WO2012163119A1 Construction and application of mutant type b human adenovirus ad11 having enhanced oncolytic power
12/06/2012WO2012142238A3 Compositions and methods for the treatment of tissue fibrosis
12/06/2012WO2012051207A3 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsp90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS
12/06/2012WO2012012710A3 Radiation sensitization agents for prostate cancer
12/06/2012WO2011134084A8 Methods, compositions, and kits for the treatment of matrix mineralization disorders
12/06/2012WO2011131360A8 Method of determining the metastatic potential of a tumor
12/06/2012WO2011117582A9 Dendritic cell inhibitory proteins from ticks
12/06/2012US20120309817 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies
12/06/2012US20120309815 Compositions and methods for topical delivery of oligonucleotides
12/06/2012US20120308565 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
12/06/2012US20120308559 Method of treating hemolytic disease
12/06/2012US20120308554 Vegf-d/vegfr2/3-mediated regulation of dendrites
12/06/2012US20120308521 Compositions and Methods for Treatment of Cancer Using Tissue-Specific Oncolytic Adenoviruses
12/05/2012EP2530161A2 Process for producing poxviruses and poxvirus compositions
12/05/2012EP2530157A2 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
12/05/2012EP2530156A1 ENA nucleic acid drugs modifying splicing in mRNA precursor
12/05/2012EP2530155A1 ENA nucleic acid drugs modifying splicing in mRNA precursor
12/05/2012EP2530154A1 ENA nucleic acid drugs modifying splicing in mRNA precursor
12/05/2012EP2530153A1 ENA nucleic acid drugs modifying splicing in mRNA precursor
12/05/2012EP2529015A2 Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1
12/05/2012EP2528626A1 Influenza nucleic acid molecules and vaccines made therefrom
12/05/2012CN102811746A Methods and compositions for nanoparticle-mediated cancer cell-targeted delivery
12/05/2012CN102808016A Applications of ARID1A gene and protein product encoded by the same
12/05/2012CN102807989A Preparation method of recombination live vector vaccines for diseases of canid and/or feline
12/05/2012CN102807613A Secreted protein with chemotactic activity and medicament usage thereof
12/05/2012CN102807609A Polypeptide for preventing and/or treating pain and application of polypeptide
12/05/2012CN102805873A Gene drug co-carrier system using cation liposome to establish gold nano-spherical shell and preparation method
12/05/2012CN102805872A HBV-heat shock protein 70 fusion gene vaccine delivered by attenuated salmonella typhimurium, and preparation and application thereof
12/05/2012CN102805870A Gold nano-spherical shell carrier with procedural gene drug release property and preparation method
12/05/2012CN102805726A siRNA (small interfering ribose nucleic acid) micro emulsion carrier and preparation method of siRNA micro emulsion carrier
12/05/2012CN102352356B Bcl11a siRNA-2292 restraining expression of BCL11A and proliferation of tumorous B cells and application thereof
12/05/2012CN102225209B Preparation method of nano magnetic granule composite system
12/05/2012CN102178960B Application of Tap73 gene in preparation of cancer stem cell chemosensitization medicine
12/05/2012CN102140461B Small interfering nucleic acid and medical composite and pharmaceutical applications of nucleic acid
12/05/2012CN101885760B HIV-1gp120 gene consensus sequence optimized by codon and gp120 nucleic acid vaccine
12/05/2012CN101367869B Polypeptide for preventing, diagnosing and treating hepatitis E virus, and vaccine as diagnosis agent of the same
12/05/2012CN101175509B Immunogenic compositions comprising lawsonia intracellularis
12/04/2012US8324449 Acellular tissue matrices made from alpha-1,3-galactose-deficient tissue
12/04/2012US8324365 Conjugate for gene transfer comprising oligonucleotide and hydrophilic polymer, polyelectrolyte complex micelles formed from the conjugate, and methods for preparation thereof
12/04/2012US8324183 Micro-RNA associated with rheumatoid arthritis
12/04/2012US8324182 Humanized model of membrane attack complex (MAC) formation on murine retina and compositions, kits and methods for treatment of macular degeneration
12/04/2012US8323963 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
12/04/2012US8323959 Microorganisms for therapy
12/04/2012US8323638 Methods and compositions for tissue regeneration
12/04/2012US8323615 Methods of processing multi-phasic dispersions
12/04/2012CA2443345C Disease-associated protein
12/04/2012CA2430582C A method for in vitro molecular evolution of protein function
12/04/2012CA2428834C Biodegradable poly(beta-amino esters) and uses thereof
12/04/2012CA2371714C Streptococcus pneumoniae proteins and vaccines
12/04/2012CA2349442C Compositions and methods for wt1 specific immunotherapy
12/04/2012CA2340304C Multicomponent vaccines
12/04/2012CA2309727C Methods for encapsulating nucleic acids in lipid bilayers
12/04/2012CA2222509C Connective tissue growth factor
11/2012
11/29/2012WO2012162705A2 Cell and gene based methods to improve cardiac function
11/29/2012WO2012162629A2 Popcorn shape gold nanoparticle for targeted diagnosis, photothermal treatment and in-situ monitoring therapy response for cancer and multiple drug resistance bacteria
11/29/2012WO2012162342A2 Influenza vaccines containing modified adenovirus vectors
11/29/2012WO2012162253A2 Use of anti-cgrp or anti-cgrp-r antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea
11/29/2012WO2012162124A1 Neuronal progenitor cells and uses
11/29/2012WO2012161806A1 Modulation of stat3 expression
11/29/2012WO2012161755A2 Antagonism of the vip signaling pathway
11/29/2012WO2012161539A2 Sirna for inhibiting the expression of bhrf1 and composition comprising same
11/29/2012WO2012161352A1 Reic-expressing adenovirus vector
11/29/2012WO2012161196A1 LIPOSOME CONTAINING shRNA MOLECULE FOR THYMIDYLATE SYNTHASE, AND USE FOR SAME
11/29/2012WO2012161124A1 Composition containing micro rna or expression system thereof
11/29/2012WO2012159550A1 Fgfr-fc fusion protein and use thereof
11/29/2012WO2012142476A9 Methods and compositions for the treatment of marfan syndrome and associated disorders
11/29/2012WO2012139099A3 Herpes simplex virus vaccine
11/29/2012WO2012129513A3 Blockage of pai-1 in diabetic cd34+ stem cells corrects cellular dysfunction
11/29/2012WO2012105813A3 Use of icam-1 for prevention or treatment of neurological diseases
11/29/2012US20120304321 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/29/2012US20120302627 Method of using adenoviral vectors to induce an immune response
11/29/2012US20120302625 Supercoiled minicircle dna for gene therapy applications
11/29/2012US20120302510 Histone deacetylases, and uses related thereto
11/29/2012US20120302491 Modulation of estrogen receptor-related receptor gamma (err gamma) and uses therefor
11/29/2012US20120301512 Tetrary Gene Delivery System for Gene Therapy and Methods of Its Use
11/29/2012US20120301485 Juvenile Hemochromatosis Gene (HFE2A) Cleavage Products and Uses Thereof
11/29/2012US20120301470 Use of tyrosine kinase inhibitors for treatment of cushing's disease and hypercortisolism
11/29/2012US20120301457 LIPID COFACTORS FOR FACILITATING PROPOGATION OF PRPsc
11/29/2012US20120301448 Th1-associated micrornas and their use for tumor immunotherapy
11/29/2012CA2836799A1 Use of anti-cgrp or anti-cgrp-r antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea
11/29/2012CA2836483A1 Neuronal progenitor cells and uses
11/29/2012CA2834584A1 Fgfr-fc fusion protein and use thereof
11/29/2012CA2825333A1 Antagonism of the vip signaling pathway
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 870